EUVIMEDEUVIMED entdecken
Fallbericht

Prevention of Opioid Induced Hyperalgesia Following Remifentanil Infusion: A Case Report

Lauren Gray

Anesthesia eJournal · 2022

DOI: 10.18776/24890y86 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Anesthesia eJournal, 2022. Verfasst von Lauren Gray.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Remifentanil, a potent µ-opioid agonist, is useful in anesthesia because of its rapid onset and short duration of action. However, the same traits that make remifentanil useful can also lead to increased pain sensation when it is discontinued. Nociceptive sensitization following opioids is termed opioid-induced hyperalgesia (OIH). Proposed preventative treatments for remifentanil-induced OIH run the spectrum of cost and feasibility. This case report will discuss the use of and rationale for readily available techniques aimed at preventing OIH. These techniques include intravenous ketamine, inhaled nitrous oxide, oral pregabalin, and gradual cessation of remifentanil infusion.

Zitieren

APA

Gray, L. (2022). Prevention of Opioid Induced Hyperalgesia Following Remifentanil Infusion: A Case Report. Anesthesia eJournal. https://doi.org/10.18776/24890y86

Vancouver

Gray L. Prevention of Opioid Induced Hyperalgesia Following Remifentanil Infusion: A Case Report. Anesthesia eJournal. 2022. doi:10.18776/24890y86

BibTeX
@article{Gray2022,
  author = {Gray, Lauren},
  title = {Prevention of Opioid Induced Hyperalgesia Following Remifentanil Infusion: A Case Report},
  journal = {Anesthesia eJournal},
  year = {2022},
  doi = {10.18776/24890y86}
}
Kostenlos starten →